Kyobo Life Insurance announced on the 8th the launch of 'Kyobo Tongkeun Cancer Insurance (Non-dividend)', which provides extensive coverage from cancer diagnosis to examination and treatment.
This product offers specialized cancer coverage such as cancer diagnosis, hospitalization, and outpatient care with just the main contract subscription. Through additional riders, the coverage scope has been expanded to include new medical technology treatments such as examinations and surgeries, as well as accident treatments.
First, upon cancer occurrence, the main contract provides benefits including (re-diagnosis) cancer diagnosis insurance payments, direct cancer treatment and cancer nursing hospital hospitalization insurance payments, and direct cancer treatment (tertiary hospital) outpatient insurance payments, increasing the benefits. For example, if the main contract subscription amount is 10 million KRW, upon confirmed cancer diagnosis, 10 million KRW is paid, and if diagnosed with re-diagnosed cancer, 5 million KRW is paid. For outpatient visits to tertiary hospitals for cancer treatment, up to 800,000 KRW per visit is covered (limited to once per day, up to 30 times annually).
Through riders covering cancer treatment and accident treatment, coverage for new cancer examinations, surgeries, and treatment methods has been strengthened, and coverage has been expanded to accidents frequently occurring in daily life.
The cancer treatment coverage rider broadly covers new cancer examinations and treatment methods such as specific NGS gene panel tests, cancer CT, PET, MRI, ultrasound examinations, da Vinci robotic surgery, targeted anticancer drug approved treatments, anticancer proton therapy, anticancer stereotactic radiotherapy, anticancer intensity-modulated radiotherapy, CAR-T anticancer drug approved treatments, and cancer-specific pain relief treatments.
Additionally, the accident treatment coverage rider provides coverage from accident surgeries and fracture treatments to cast treatments and flu treatments.
This product is a non-renewable cancer insurance that provides cancer coverage until maturity without monthly premium increases, and at maturity, the full maturity refund is returned not only for the main contract but also for the rider premiums. To enable faster preparation for cancer coverage, the minimum eligible age for subscription has been expanded to 0 years old.
A Kyobo Life Insurance official stated, "Reflecting trends in cancer coverage, we have introduced cancer insurance that provides extensive coverage from cancer diagnosis to examination and treatment," and added, "Through differentiated additional services specialized for cancer coverage, we expect to be a reliable partner that supports customers' healthy lives and balanced protection."
Subscription is available from ages 0 to 40, with a 30-year maturity period. Premium payment options include lump-sum payment or 5, 10, 15, or 20-year payment plans.
Customers who choose lump-sum payment or have a monthly premium of 30,000 KRW or more will receive the 'Kyobo Healthcare Service Cancer Specialized Plan.' This service offers various programs covering overall health management, disease prevention management, general treatment support, cancer specialization, and support for treatment of the three major diseases, covering the entire process from cancer diagnosis to treatment. In particular, for treatment support of the three major diseases, customers can select services tailored to their situation, such as nurse accompaniment, caregiver support, or daily life support.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
